AS THE INFORMATION LANDSCAPE CHANGES, SO MUST MEDICAL AFFAIRS
Medical Affairs is facing a rapidly evolving information landscape where misinformation, digital influence, and AI are reshaping how science is accessed and trusted. To stay effective, the function must move beyond accuracy alone and build agile, “trusted architectures” that ensure scientific information is visible, accessible, and meaningful across both human and AI-driven channels.
THE END OF THE ERA OF KITCHEN SINK CONTENT IS NIGH
After attending the 2026 Veeva Commercial & Medical Summit, one theme became impossible to ignore: pharma marketing’s era of “kitchen sink” content must end. As AI accelerates content creation, the real challenge is no longer producing more materials, it’s creating focused, high-value IVA content that actually supports meaningful Rep/HCP interactions.
AI‑ENABLED HUMAN REPRESENTATION IN PHARMACEUTICAL MARKETING
AI-generated human imagery is reshaping pharmaceutical marketing, offering new opportunities for scale and efficiency while raising the stakes for authenticity, governance, and patient trust. The challenge is no longer whether to use AI, but how to apply it responsibly.
MARKET ACCESS IS ENTERING ITS COLLABORATIVE ERA
Market access is no longer a final step—it’s becoming a foundational strategy. Insights from Asembia’s AXS26 Summit highlight a clear shift toward earlier integration, clearer data storytelling, and deeper collaboration across payers, manufacturers, and partners to navigate an increasingly complex healthcare landscape.
WHAT ADOBE SUMMIT REMINDED ME ABOUT PHARMA’S BIGGEST MISSED OPPORTUNITY
Day 1 at Adobe Summit felt like a wake-up call on what’s now possible. Relevance is a data problem, and while healthcare has the data, it’s often too siloed to act on. The real challenge is building operating models that deliver the speed and personalization customers already expect.
WHAT JPM26 REALLY TOLD US ABOUT HEALTHCARE COMMUNICATIONS
Insights from JPM26 showed oncology, AI-enabled innovation and CEO visibility dominating pharma conversations, as companies shift focus from reinvention to delivery. In an increasingly competitive landscape, strong differentiation and strategic communications will be key to standing out.
PUBLICIS HEALTH GLOBAL CEO MATT MCNALLY TAPS IN FOR 2026
Matt McNally discusses his return to Publicis Health, the network’s recent growth, and what’s ahead for healthcare marketing in 2026. In the MM+M podcast interview, McNally also shares insights on leadership and the evolving industry landscape.
THE CREATIVE RENAISSANCE AND MODERN MARKETING
Learn how Publicis Health and Digitas Health foster global connections, cross-industry inspiration, and human-centered creative strategies in healthcare marketing.

